GTG hails successful year despite mixed results

By Dylan Bushell-Embling
Wednesday, 03 September, 2008


Genetic Technologies [ASX: GTG] has reported what company representatives believe to be positive financial year results, even though it experienced a consolidated loss of over $5 million.

Consolidated loss after tax for FY08 was up 25 per cent to $5.4 million, despite a five per cent increase in revenue to $15.7 million and positive net cash flows from operations.

As a result of this loss, the company has no plans to pay share dividends, and the company's consolidated net tangible assets have decreased from four to 3.83 cents per share.

According to GTG, these losses resulted from amortisation of patents, impairment losses, depreciation of plant and equipment, foreign exchange losses and share-based payment expenses.

Over the period, GTG also acquired the Frozen Puppies Dot Com business and a 15 per cent stake in a mining venture.

The company also continued to develop products which are coming closer to commercialisation, it said.

Related Articles

Aussie biotech to manufacture mRNA paediatric brain cancer vaccines

A Queensland-based biotechnology company will manufacture personalised mRNA paediatric brain...

Who's afraid of killer whales? — white sharks and prolonged absences

Is killer whale predation the sole driver of white shark long absence? Australian researchers...

Five scenarios for the future of Antarctic life

A team of Australian and international researchers have predicted five possible outcomes for how...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd